Why Some Keratitis Cases Fail Treatment: Hidden Clinical Pitfalls

Introduction

Keratitis is one of the most time-sensitive ophthalmic conditions encountered in clinical practice. With prompt diagnosis and appropriate antimicrobial therapy, most cases of infectious keratitis can be controlled effectively.

Slit Lamp Adapter

Slit Lamp Adapter - Get

However, in real-world practice, a subset of patients shows poor or incomplete response despite apparently adequate treatment.

These “non-responding keratitis cases” represent a significant diagnostic and therapeutic challenge.

Treatment failure is not always due to drug resistance or incorrect medication choice; in many cases, the underlying issue is a missed diagnosis, an unrecognized organism, or a hidden clinical pitfall that alters disease behavior.

For ophthalmologists, recognizing these pitfalls early can be the difference between corneal clarity and irreversible vision loss.

Why Keratitis Treatment Fails: The Core Problem

Treatment failure in keratitis is rarely random. It usually falls into one of three categories:

Incorrect initial diagnosis (infectious vs non-infectious)
Inadequate or inappropriate therapy
Host or structural factors preventing resolution

👉 The most dangerous assumption is that “non-response = resistant organism,” while in reality, many cases are misclassified from the beginning.

Hidden Diagnostic Pitfalls

1. Misdiagnosing the Etiology (Bacterial vs Fungal vs Acanthamoeba)

One of the most common reasons for treatment failure is incorrect identification of the causative organism.

Bacterial keratitis → usually responds to fortified antibiotics
Fungal keratitis → requires antifungal therapy and worsens with steroids
Acanthamoeba keratitis → often mimics epithelial disease and is highly resistant to standard antibiotics

👉 Early fungal or protozoal keratitis often mimics bacterial ulcers clinically, leading to inappropriate treatment.

2. Early Steroid Misuse

Corticosteroids are a double-edged sword in keratitis management.

While they may reduce inflammation in selected bacterial cases, premature use can:

Suppress local immune response
Accelerate fungal proliferation
Mask clinical progression
Delay epithelial healing

👉 One of the most critical pitfalls is starting steroids before microbiological confirmation.

3. Inadequate Corneal Scraping or Missed Microbiology

Failure to perform proper diagnostic sampling leads to empirical treatment that may not match the pathogen.

Common issues include:

Superficial scraping in deep stromal infections
Failure to culture on appropriate media
Missing repeat scraping in non-responders

👉 Any keratitis not improving within 48–72 hours should be re-scraped.

Hidden Infectious Pitfalls

4. Atypical Organisms

Some organisms behave differently and do not respond to standard regimens.

Examples include:

Fusarium species → aggressive fungal keratitis with poor drug penetration
Nocardia → slow-growing, often mistaken for fungal infection
Herpetic keratitis → can mimic bacterial ulcers but worsens with steroids
Acanthamoeba → severe pain out of proportion to clinical signs

👉 A mismatch between clinical appearance and pain severity is often a diagnostic clue.

5. Polymicrobial Infections

Mixed infections are more common than often appreciated, especially in:

Contact lens users
Trauma cases
Chronic ocular surface disease

Bacteria + fungi or bacteria + protozoa combinations can lead to partial treatment response.

👉 Treating only one organism leads to apparent “treatment failure.”

Structural and Host-Related Pitfalls

6. Ocular Surface Disease

Underlying surface abnormalities can prevent healing:

Severe dry eye disease
Neurotrophic keratopathy
Limbal stem cell deficiency
Chronic blepharitis

Even when infection is controlled, epithelial healing fails.

7. Corneal Biofilm Formation

Some pathogens form biofilms on corneal tissue or contact lenses, leading to:

Antibiotic resistance
Chronic low-grade infection
Recurrent inflammation

👉 Biofilms significantly reduce drug penetration and efficacy.

8. Delayed Presentation and Advanced Disease

Late presentation leads to:

Deep stromal involvement
Endothelial damage
Impending perforation

At this stage, medical therapy alone may be insufficient.

Clinical Red Flags of Treatment Failure

Ophthalmologists should suspect a hidden pitfall when they observe:

No improvement after 48–72 hours of intensive therapy
Worsening infiltrate despite treatment
Increasing pain or disproportionate pain
Appearance of satellite lesions or feathery borders
New hypopyon or worsening anterior chamber reaction

👉 “Stable but not improving” is itself a warning sign.

Role of Imaging in Non-Responding Keratitis

Advanced imaging can uncover hidden pathology.

Anterior Segment OCT

Depth of infiltrate
Stromal necrosis
Descemet involvement

Confocal Microscopy

Fungal filaments
Acanthamoeba cysts and trophozoites
In vivo microbial visualization

👉 These tools are especially useful when cultures are negative.

Management Strategy in Failed Keratitis

When keratitis does not respond, a structured approach is essential:

1. Re-evaluate Diagnosis

Repeat scraping
Consider fungal, viral, or protozoal causes

2. Modify Therapy Based on Response

Switch antimicrobial class
Add antifungal or anti-amoebic agents if suspected

3. Avoid Blind Steroid Use

Only consider after clear infection control in bacterial cases

4. Address Underlying Surface Disease

Lubrication
Lid hygiene
Neurotrophic support

5. Consider Surgical Options

Amniotic membrane graft
Therapeutic keratoplasty in perforation risk

Steroids Revisited: The Most Common Clinical Trap

The misuse of steroids remains one of the most important causes of worsening keratitis.

Steroids may:

Improve symptoms temporarily
Reduce redness
Create false clinical stability

But at the same time, they may:

Allow unchecked microbial proliferation
Delay definitive diagnosis
Increase the perforation risk in fungal disease

👉 In infectious keratitis, timing of steroids is more important than the drug itself.

Conclusion

Treatment failure in keratitis is rarely due to a single factor. It is usually the result of hidden clinical pitfalls involving misdiagnosis, inadequate microbiological workup, inappropriate steroid use, atypical organisms, or underlying ocular surface disease.

For ophthalmologists, the key principle is simple:

When keratitis does not respond as expected, reconsider the diagnosis before escalating the same treatment.

Early recognition of these pitfalls not only improves outcomes but also prevents irreversible corneal damage and vision loss.

HOW TO TAKE SLIT-LAMP EXAM IMAGES WITH A SMARTPHONE?

Smartphone slit-lamp photography is a new advancement in the field of science and technology, in which photographs of the desired slit-lamp finding can be taken with smartphones by using the slit-lamp adapters.

Slit-lamp Smartphone photography

References

Thomas PA, et al. “Infectious keratitis: pathogenesis and management.” Clin Microbiol Rev. 2020.
Ting DSJ, et al. “Infectious keratitis: update on epidemiology and management.” Eye (Lond). 2021.
Wilhelmus KR. “Indecision about corticosteroids in keratitis.” Ophthalmology. 2002.
Srinivasan M. “Fungal keratitis.” Curr Opin Ophthalmol. 2004.
Alfonso EC, et al. “Acanthamoeba keratitis.” Surv Ophthalmol. 2019.
Dart JK, et al. “Microbial keratitis management strategies.” Eye. 2015.
Sharma N, et al. “Microbial keratitis clinical profile.” Br J Ophthalmol. 2010.
Garg P. “Diagnosis of microbial keratitis.” Br J Ophthalmol. 2010.